These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2375922)

  • 1. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
    Visani G; Finelli C; Castelli U; Petti MC; Ricci P; Vianelli N; Gianni L; Zuffa E; Aloe Spiriti MA; Latagliata R
    Br J Haematol; 1990 May; 75(1):4-9. PubMed ID: 2375922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
    Mesa RA; Li CY; Schroeder G; Tefferi A
    Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelofibrosis with myeloid metaplasia. A study of 24 consecutive patients].
    Bettini R; Redaelli S; Marzetta K; Maino C; Sala D; Saccà V; Gorini M
    Recenti Prog Med; 2004; 95(7-8):358-64. PubMed ID: 15303545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients.
    Arora B; Sirhan S; Hoyer JD; Mesa RA; Tefferi A
    Br J Haematol; 2005 Jan; 128(1):42-8. PubMed ID: 15606548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
    Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
    Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: an update anno 2000.
    Cervantes F
    Pathol Biol (Paris); 2001 Mar; 49(2):148-52. PubMed ID: 11317960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.
    Sagaster V; Jäger E; Weltermann A; Schwarzinger I; Gisslinger H; Lechner K; Geissler K; Oehler L
    Haematologica; 2003 Nov; 88(11):1204-12. PubMed ID: 14607748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
    Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
    Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic myelofibrosis (agnogenic myeloid metaplasia): clinicopathological analysis of 32 patients.
    Ozen S; Ferhanoğlu B; Senocak M; Tüzüner N
    Leuk Res; 1997 Feb; 21(2):125-31. PubMed ID: 9112429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
    Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
    Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melphalan treatment in patients with myelofibrosis with myeloid metaplasia.
    Petti MC; Latagliata R; Spadea T; Spadea A; Montefusco E; Aloe Spiriti MA; Avvisati G; Breccia M; Pescarmona E; Mandelli F
    Br J Haematol; 2002 Mar; 116(3):576-81. PubMed ID: 11849213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia in myelofibrosis: its value in prognosis.
    Njoku OS; Lewis SM; Catovsky D; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):79-89. PubMed ID: 6849838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger: presenting features, evolution and survival.
    Cervantes F; Barosi G; Hernández-Boluda JC; Marchetti M; Montserrat E
    Eur J Haematol; 2001 May; 66(5):324-7. PubMed ID: 11422412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.
    Rupoli S; Da Lio L; Sisti S; Campanati G; Salvi A; Brianzoni MF; D'Amico S; Cinciripini A; Leoni P
    Ann Hematol; 1994 Apr; 68(4):205-12. PubMed ID: 8003563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasia.
    Tefferi A; Jiménez T; Gray LA; Mesa RA; Chen MG
    Eur J Haematol; 2001 Jan; 66(1):37-42. PubMed ID: 11168506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
    Akpek G; McAneny D; Weintraub L
    J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups.
    Cervantes F; Barosi G; Demory JL; Reilly J; Guarnone R; Dupriez B; Pereira A; Montserrat E
    Br J Haematol; 1998 Aug; 102(3):684-90. PubMed ID: 9722294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.